Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women

Oral et al., NCT05318144, NCT05318144, Feb 2022

Melatonin for COVID-19

22nd treatment shown to reduce risk in May 2021, now with p = 0.000000015 from 18 studies.

No treatment is 100% effective.
Protocols combine treatments.